Medicare Enrolled
Dr. Samir Kubba, M.D.
Hematology & Oncology · San Bernardino, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kubba from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kubba?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kubba
Dr. Samir Kubba is a hematology & oncology specialist in San Bernardino, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kubba performed 11,068 Medicare services across 999 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kubba received a total of $25,493 from 105 pharmaceutical and/or device companies across 1145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kubba is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 28% volume in CA
$25,493 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,068
Medicare services
Top 28% in CA for hematology & oncology
999
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~553 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,682 | $0 | $3 |
| Injection, granisetron hydrochloride, 100 mcg | 2,180 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,480 | $6 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
856 | $94 | $140 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
516 | $8 | $15 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
402 | $24 | $59 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
330 | $53 | $104 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
290 | $64 | $95 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
289 | $6 | $7 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
228 | $107 | $268 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
138 | $1 | $3 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
117 | $11 | $35 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
113 | $7 | $15 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
89 | $55 | $118 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
76 | $0 | $5 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
74 | $24 | $60 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
59 | $27 | $90 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
49 | $1 | $5 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
47 | $10 | $40 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $141 | $255 |
| New patient office visit, complex (60-74 min) | 14 | $180 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.0% high complexity
71.5% medium
18.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,493
Total received (2018-2024)
Avg $3,642/year across 7 years
Top 18% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
105
Companies
1,145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,272 (87.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,869 (7.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,352 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,597
2023
$5,054
2022
$3,674
2021
$3,286
2020
$2,935
2019
$3,891
2018
$3,054
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$393
Merck Sharp & Dohme LLC
$379
AstraZeneca Pharmaceuticals LP
$361
Novartis Pharmaceuticals Corporation
$334
E.R. Squibb & Sons, L.L.C.
$197
PFIZER INC.
$183
Gilead Sciences, Inc.
$168
Incyte Corporation
$139
ABBVIE INC.
$116
Lilly USA, LLC
$87
ARRAY BIOPHARMA INC
$81
Regeneron Healthcare Solutions, Inc.
$77
BeiGene USA, Inc.
$77
GlaxoSmithKline, LLC.
$66
Ipsen Biopharmaceuticals, Inc
$65
Eisai Inc.
$65
Celgene Corporation
$58
Tempus AI, Inc
$57
Genentech USA, Inc.
$57
SpringWorks Therapeutics, Inc.
$55
Daiichi Sankyo Inc.
$52
CSL Behring
$48
PUMA BIOTECHNOLOGY, INC.
$42
GENZYME CORPORATION
$39
Takeda Pharmaceuticals U.S.A., Inc.
$33
Blueprint Medicines Corporation
$30
Rigel Pharmaceuticals, Inc.
$28
Pharmacosmos Therapeutics Inc.
$28
Aveo Pharmaceuticals, Inc.
$26
Kyowa Kirin, Inc.
$26
Legend Biotech USA Inc.
$23
Astellas Pharma US Inc
$23
SOBI, INC
$22
Karyopharm Therapeutics Inc.
$20
ADC Therapeutics America, Inc.
$20
Kite Pharma, Inc.
$20
TAIHO ONCOLOGY, INC.
$19
JAZZ PHARMACEUTICALS INC.
$19
Adaptive Biotechnologies Corporation
$19
Agios Pharmaceuticals, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$16
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 31.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,942
Novartis Pharmaceuticals Corporation
$2,107
Janssen Biotech, Inc.
$1,450
E.R. Squibb & Sons, L.L.C.
$1,389
Merck Sharp & Dohme LLC
$873
Merck Sharp & Dohme Corporation
$793
Amgen Inc.
$775
PFIZER INC.
$761
GENZYME CORPORATION
$740
Celgene Corporation
$676
Genentech USA, Inc.
$669
Incyte Corporation
$668
Gilead Sciences, Inc.
$594
Astellas Pharma US Inc
$572
BeiGene USA, Inc.
$545
Seagen Inc.
$509
CSL Behring
$455
GlaxoSmithKline, LLC.
$448
Takeda Pharmaceuticals U.S.A., Inc.
$416
Daiichi Sankyo Inc.
$375
Pharmacyclics LLC, An AbbVie Company
$371
Bayer HealthCare Pharmaceuticals Inc.
$371
Athenex Pharmaceutical Division, LLC
$350
Foundation Medicine, Inc.
$313
Lilly USA, LLC
$273
Karyopharm Therapeutics Inc.
$269
Alexion Pharmaceuticals, Inc.
$260
Teva Pharmaceuticals USA, Inc.
$257
COMSORT, Inc
$250
Puma Biotechnology, Inc.
$212
Novocure GmbH
$200
Regeneron Healthcare Solutions, Inc.
$189
PUMA BIOTECHNOLOGY, INC.
$173
ABBVIE INC.
$161
Ipsen Biopharmaceuticals, Inc
$161
Eisai Inc.
$158
EMD Serono, Inc.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Myovant Sciences Inc.
$151
Kite Pharma, Inc.
$147
Sumitomo Pharma America, Inc.
$140
Abbott Laboratories
$138
TESARO, Inc.
$112
SANOFI-AVENTIS U.S. LLC
$100
ARRAY BIOPHARMA INC
$97
EISAI INC.
$97
Dova Pharmaceuticals
$96
Rigel Pharmaceuticals, Inc.
$93
SOBI, INC
$91
Exelixis Inc.
$89
AbbVie, Inc.
$80
Taiho Oncology, Inc.
$80
Global Blood Therapeutics, Inc.
$80
Epizyme, Inc.,
$79
TOLMAR Pharmaceuticals, Inc.
$76
AVEO Pharmaceuticals, Inc.
$76
PharmaEssentia USA Corporation
$63
Tempus AI, Inc
$57
Emmaus Medical, Inc.
$57
Aveo Pharmaceuticals, Inc.
$55
SpringWorks Therapeutics, Inc.
$55
Sobi, Inc
$53
Pharmacosmos Therapeutics Inc.
$52
AMAG Pharmaceuticals, Inc.
$50
Helsinn Therapeutics (U.S.), Inc.
$49
ImmunoGen, Inc.
$49
Verastem, Inc.
$48
Dendreon Pharmaceuticals LLC
$46
EUSA Pharma (US) LLC
$45
Spectrum Pharmaceuticals Inc.
$42
MorphoSys, US Inc.
$42
Sun Pharmaceutical Industries Inc.
$39
TAIHO ONCOLOGY, INC.
$37
Adaptive Biotechnologies Corporation
$37
Heron Therapeutics, Inc.
$37
Octapharma USA, Inc.
$36
SERVIER PHARMACEUTICALS LLC
$35
JAZZ PHARMACEUTICALS INC.
$34
Bayer Healthcare Pharmaceuticals Inc.
$34
Deciphera Pharmaceuticals Inc.
$32
INSYS Therapeutics Inc
$31
Blueprint Medicines Corporation
$30
Janssen Pharmaceuticals, Inc
$29
Janssen Scientific Affairs, LLC
$28
Kyowa Kirin, Inc.
$26
Secura Bio, Inc.
$26
CTI BioPharma Corp.
$25
AbbVie Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$24
Acceleron Pharma, Inc.
$23
Legend Biotech USA Inc.
$23
Array BioPharma Inc.
$22
Fennec Pharmaceuticals, Inc.
$22
TerSera Therapeutics LLC
$21
Mylan Institutional Inc.
$20
ADC Therapeutics America, Inc.
$20
Aurobindo Pharma USA, Inc.
$19
Acrotech Biopharma LLC
$19
Novo Nordisk Inc
$19
GE HEALTHCARE
$19
Grifols USA, LLC
$18
Seattle Genetics, Inc.
$18
Horizon Therapeutics plc
$17
Agios Pharmaceuticals, Inc.
$17
Advanced Accelerator Applications
$16
Top 3 companies account for 25.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AJOVY · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Endari · Enhertu · Erleada · Esperoct · FARYDAK · FASLODEX · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · Folotyn · Fulphila · GAZYVA · GILOTRIF · Gamunex-C · HEMLIBRA · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRYSTEXXA · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Mitra Clip system · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
42
Per 100K population
1.9
County median income
$82,184
Nearest hospital
ST BERNARDINE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kubba is a mixed practice specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kubba experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Kubba performed 3,682 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kubba receive payments from pharmaceutical companies?
Yes. Dr. Kubba received a total of $25,493 from 105 companies across 1,145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kubba's costs compare to other hematology & oncology specialists in San Bernardino?
Dr. Kubba's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kubba) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Bernardino
Browse hematology & oncology specialists in San Bernardino ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology